Lean Mass and Musculoskeletal Preservation in GLP-1-Based Obesity Treatment: Nutrition, Exercise, Supplementation, and Monitoring Strategies

<b>Background/Objectives:</b> GLP-1-based obesity pharmacotherapy has shifted clinical attention from the magnitude of weight loss to the quality of weight loss. This review evaluates whether body composition changes during treatment with GLP-1-based agents represent clinically meaningful muscle los...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Roko Šantić, Lovre Martinović, Nikola Pavlović, Doris Rušić, Marko Kumrić, Dinko Martinović, Tina Tičinović Kurir, Joško Božić
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	MDPI AG 2026-05-01
Saila:	Metabolites
Gaiak:	GLP-1 receptor agonists semaglutide tirzepatide skeletal muscle mass obesity protein intake
Sarrera elektronikoa:	https://www.mdpi.com/2218-1989/16/6/364
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!